PCI Biotech to present at DNB Health Care Conference 2015

Posted on Dec 15, 2015

Lysaker, 15 December 2015 – PCI Biotech will present at DNB Health Care Conference today 12:45 local time at DNB Head Office, Oslo, Norway. The company will be represented by Dr. Per Walday, CEO. 1512 PCIB DNB Health Care Conf About PCI Biotech PCI Biotech is a cancer focused biopharmaceutical company headquartered in Norway and […]

Mandatory notification of trade – employee share option scheme

Posted on Nov 30, 2015

Lysaker, 27 November 2015 – In accordance with the authorization granted by the Annual General Meeting 13th May 2014, the Board of Directors of PCI Biotech Holding ASA has awarded a total of 110,000 options to key employees. Each option gives the right to subscribe for or acquire one share per option (after PCI Biotech […]

PCI Biotech 3rd Quarter report

Posted on Nov 17, 2015

Lysaker, 17th November 2015 – Please find attached the third quarter 2015 report for PCI Biotech Holding ASA. Q3 2015 report Highlights include: Research collaboration with a top-10 large pharma company initiated The bile duct study has moved into the fourth dose cohort Research collaboration with RXi progressing according to plan Scientific Advisory Committee established […]